Our recent activity

Amelia Virtual Care welcomes new investors and strengthens its management team

● ENDRA and CDTI Innvierte lead the new investment bringing up to €7million the total funds raised by the company in the last year, together with current investors Sabadell Asabys, Caixa Capital Risc and CG Ventures
● Amelia Virtual Care, previously known as Psious, appoints Afsana Akhter as CEO and Raúl Peris as General Director of Operations
● The funds raised and the new management team will boost the company’s growth in United States

Amelia Virtual Care, mental health technology company with offices in Barcelona and San Francisco, announces today the appointment of Afsana Akhter as new CEO, and Raúl Peris as General Director of Operations, executives with an extensive track record in the healthtech industry in Europe and the US. The company has also received new funding from ENDRA, international pledge fund managed from London, and CDTI, entity dependent of the Spanish Ministry of Science and Innovation with its venture capital program called Innvierte.

Amelia has developed the largest and most complete virtual reality platform in mental health, allowing professionals to treat a wide range of mental health disorders from common phobias to anxiety and depression. With over 60 employees and more than 200,000 VR sessions delivered, Amelia is present worldwide being the United States its main market. The new financing and management team will boost the company’s growth in this market, strengthening its commercial activity and clinical evidence.

Afsana Akhter, CEO, has a long-time experience working with the main healthcare providers and payers in the US in American companies such as Livongo and Kiio. Raúl Peris, General Director of Operations, has a strong track record growing and leading the operations of technology companies such as Savana Medical, Cimpress and Vistaprint.

In 2019 Amelia closed a €6 million Series A led by Sabadell Asabys and Caixa Capital Risc which allowed them to further develop its technology and consolidate its presence in Europe and the US.

“Amelia is a great example of innovation, job well done and internationalization that has created a leader in an industry that is being transformed by technology. The application of VR to improve mental health is a high-growth business where Amelia has become a world leader with more than half of its business in the US”, comments Toni Bonet, founding partner of ENDRA.

“We are excited to welcome our new investors ENDRA and CDTI Innvierte and thankful for the continued support of our existing investors. The benefits of virtual reality in mental health are proven through 30 years of scientific research, and adoption of VR is on a fast upward trend. Amelia offers a proven solution at the intersection of mental health and the metaverse. These funds will help fuel Amelia’s strong growth in the U.S. market and globally, in support of our mission to empower Healthcare Providers with VR and advanced technologies to improve mental health worldwide”, adds Afsana Akhter, CEO of Amelia Virtual Care.

 

About Amelia Virtual Care

Amelia Virtual Care provides evidence-based virtual reality tools for mental health professionals to use in their practice. The company’s VR platform is used by over 2,000 therapists across the globe to enhance patient therapy for both in-person and remote environments. www.ameliavirtualcare.com

Portfolio
July 13, 2022

Agomab Raises Additional $40.5 Million Through Series B Extension Bringing Total Amount to $114M

READ THIS NEWS IN SPANISH ● Extension led by Pfizer with participation from new investors Walleye Capital and Asabys Partners as well as existing investors ● Funding will support next…
Portfolio
June 28, 2022

Amelia Virtual Care welcomes new investors and strengthens its management team

READ THIS NEWS IN SPANISHAmelia Virtual Care, mental health technology company with offices in Barcelona and San Francisco, announces today the appointment of Afsana Akhter as new CEO, and Raúl…
Portfolio
May 13, 2022

Digital digestive health therapeutic Cara Care lands $7M investment, appoints James “Jim” Mapes CEO

READ THIS NEWS IN SPANISHCara Care announced a $7M equity financing round today led by family-owned international food and nutrition manufacturer Dr. Schär AG, alongside existing investors Sabadell Asabys and…